The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand

Background Isoniazid (INH) is metabolized by polymorphic N-acetyltransferase 2 (NAT2) enzyme, which noticeably alters INH plasma concentration. We aimed to determine the distribution of NAT2 genotype in Thai tuberculosis (TB) patients and correlate their genotype with plasma INH concentrations. Meth...

Full description

Bibliographic Details
Main Authors: Usanee Ungcharoen, Hutcha Sriplung, Surakameth Mahasirimongkol, Saranyou Chusri, Nuanjun Wichukchinda, Phongpan Mokmued, Sukanya Wattanapokayakit, Virasakdi Chongsuvivatwong
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2020-12-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
Online Access:http://www.e-trd.org/upload/pdf/trd-2020-0068.pdf
_version_ 1818944989410885632
author Usanee Ungcharoen
Hutcha Sriplung
Surakameth Mahasirimongkol
Saranyou Chusri
Nuanjun Wichukchinda
Phongpan Mokmued
Sukanya Wattanapokayakit
Virasakdi Chongsuvivatwong
author_facet Usanee Ungcharoen
Hutcha Sriplung
Surakameth Mahasirimongkol
Saranyou Chusri
Nuanjun Wichukchinda
Phongpan Mokmued
Sukanya Wattanapokayakit
Virasakdi Chongsuvivatwong
author_sort Usanee Ungcharoen
collection DOAJ
description Background Isoniazid (INH) is metabolized by polymorphic N-acetyltransferase 2 (NAT2) enzyme, which noticeably alters INH plasma concentration. We aimed to determine the distribution of NAT2 genotype in Thai tuberculosis (TB) patients and correlate their genotype with plasma INH concentrations. Methods Blood samples from 55 newly diagnosed pulmonary tuberculosis participants from three hospitals were collected to classify the subject by NAT2 genotype performed by the Multiplex haplotype-specific polymerase chain reaction method. Patients were grouped into three acetylators (fast, intermediate, and slow). On day 14 of tuberculosis treatment, the second blood sample was taken to estimate the peak plasma concentration at 2 hours after oral administration. INH plasma concentration was analyzed by liquid chromatography‒tandem mass spectrometry/mass spectrometry method. Results The NAT2 genotype distribution of fast, intermediate, and slow acetylator was 10.9%, 36.4%, and 52.7%, from six, 20, and 29 patients, respectively. The median (interquartile range) of INH plasma concentration at 2 hours post drug administration for these three genotypes were 0.75 (0.69–0.86), 2.56 (2.12–3.97), and 4.25 (3.56–5.50) µg/mL from four, 14, and 12 cases, respectively. The INH plasma concentration at 2 hours after administration was significantly associated with body weight and NAT2 acetylator. Conclusion The INH plasma concentration was found lower in fast than intermediate and slow acetylators. Body weight and NAT2 acetylator influenced INH plasma concentrations at 2 hours after drug administration. Therefore, the NAT2 genotype should be known before starting TB treatment to maximize therapeutic outcomes.
first_indexed 2024-12-20T07:51:59Z
format Article
id doaj.art-f696a40629924235b2b42fc46a9e1601
institution Directory Open Access Journal
issn 1738-3536
2005-6184
language English
last_indexed 2024-12-20T07:51:59Z
publishDate 2020-12-01
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format Article
series Tuberculosis and Respiratory Diseases
spelling doaj.art-f696a40629924235b2b42fc46a9e16012022-12-21T19:47:48ZengThe Korean Academy of Tuberculosis and Respiratory DiseasesTuberculosis and Respiratory Diseases1738-35362005-61842020-12-0183Supple 1S55S6210.4046/trd.2020.00683296The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern ThailandUsanee Ungcharoen0Hutcha Sriplung1Surakameth Mahasirimongkol2Saranyou Chusri3Nuanjun Wichukchinda4Phongpan Mokmued5Sukanya Wattanapokayakit6Virasakdi Chongsuvivatwong7 Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand Division of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand Division of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand Division of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand Division of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, ThailandBackground Isoniazid (INH) is metabolized by polymorphic N-acetyltransferase 2 (NAT2) enzyme, which noticeably alters INH plasma concentration. We aimed to determine the distribution of NAT2 genotype in Thai tuberculosis (TB) patients and correlate their genotype with plasma INH concentrations. Methods Blood samples from 55 newly diagnosed pulmonary tuberculosis participants from three hospitals were collected to classify the subject by NAT2 genotype performed by the Multiplex haplotype-specific polymerase chain reaction method. Patients were grouped into three acetylators (fast, intermediate, and slow). On day 14 of tuberculosis treatment, the second blood sample was taken to estimate the peak plasma concentration at 2 hours after oral administration. INH plasma concentration was analyzed by liquid chromatography‒tandem mass spectrometry/mass spectrometry method. Results The NAT2 genotype distribution of fast, intermediate, and slow acetylator was 10.9%, 36.4%, and 52.7%, from six, 20, and 29 patients, respectively. The median (interquartile range) of INH plasma concentration at 2 hours post drug administration for these three genotypes were 0.75 (0.69–0.86), 2.56 (2.12–3.97), and 4.25 (3.56–5.50) µg/mL from four, 14, and 12 cases, respectively. The INH plasma concentration at 2 hours after administration was significantly associated with body weight and NAT2 acetylator. Conclusion The INH plasma concentration was found lower in fast than intermediate and slow acetylators. Body weight and NAT2 acetylator influenced INH plasma concentrations at 2 hours after drug administration. Therefore, the NAT2 genotype should be known before starting TB treatment to maximize therapeutic outcomes.http://www.e-trd.org/upload/pdf/trd-2020-0068.pdfisoniazid genotypen-acetyltransferase 2plasma concentrationtuberculosis
spellingShingle Usanee Ungcharoen
Hutcha Sriplung
Surakameth Mahasirimongkol
Saranyou Chusri
Nuanjun Wichukchinda
Phongpan Mokmued
Sukanya Wattanapokayakit
Virasakdi Chongsuvivatwong
The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
Tuberculosis and Respiratory Diseases
isoniazid
genotype
n-acetyltransferase 2
plasma concentration
tuberculosis
title The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
title_full The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
title_fullStr The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
title_full_unstemmed The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
title_short The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
title_sort influence of nat2 genotypes on isoniazid plasma concentration of pulmonary tuberculosis patients in southern thailand
topic isoniazid
genotype
n-acetyltransferase 2
plasma concentration
tuberculosis
url http://www.e-trd.org/upload/pdf/trd-2020-0068.pdf
work_keys_str_mv AT usaneeungcharoen theinfluenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT hutchasriplung theinfluenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT surakamethmahasirimongkol theinfluenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT saranyouchusri theinfluenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT nuanjunwichukchinda theinfluenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT phongpanmokmued theinfluenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT sukanyawattanapokayakit theinfluenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT virasakdichongsuvivatwong theinfluenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT usaneeungcharoen influenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT hutchasriplung influenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT surakamethmahasirimongkol influenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT saranyouchusri influenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT nuanjunwichukchinda influenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT phongpanmokmued influenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT sukanyawattanapokayakit influenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand
AT virasakdichongsuvivatwong influenceofnat2genotypesonisoniazidplasmaconcentrationofpulmonarytuberculosispatientsinsouthernthailand